Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment - a comparative study

被引:32
作者
Angeles Via-Sosa, M. [1 ]
Lopes, Natali [2 ]
March, Marian [1 ]
机构
[1] Univ Barcelona, Fac Pharm, Unidad Pract Tuteladas, E-08007 Barcelona, Spain
[2] Univ Barcelona, Fac Pharm, E-08007 Barcelona, Spain
来源
BMC FAMILY PRACTICE | 2013年 / 14卷
关键词
Drug dosing service; Community pharmacist; Renal impairment; Polymedication; Elderly patients; CHRONIC KIDNEY-DISEASE; HOSPITALIZED-PATIENTS; ADJUSTMENTS; PREVALENCE; EQUATIONS; DIET;
D O I
10.1186/1471-2296-14-96
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Drug dosing errors are common in renal-impaired patients. Appropriate dosing adjustment and drug selection is important to ensure patients' safety and to avoid adverse drug effects and poor outcomes. There are few studies on this issue in community pharmacies. The aims of this study were, firstly, to determine the prevalence of dosing inadequacy as a consequence of renal impairment in patients over 65 taking 3 or more drug products who were being attended in community pharmacies and, secondly, to evaluate the effectiveness of the community pharmacist's intervention in improving dosing inadequacy in these patients when compared with usual care. Methods: The study was carried out in 40 Spanish community pharmacies. The study had two phases: the first, with an observational, multicentre, cross sectional design, served to determine the dosing inadequacy, the drug-related problems per patient and to obtain the control group. The second phase, with a controlled study with historical control group, was the intervention phase. When dosing adjustments were needed, the pharmacists made recommendations to the physicians. A comparison was made between the control and the intervention group regarding the prevalence of drug dosing inadequacy and the mean number of drug-related problems per patient. Results: The mean of the prevalence of drug dosing inadequacy was 17.5% [95% CI 14.6-21.5] in phase 1 and 15.5% [95% CI 14.5-16.6] in phase 2. The mean number of drug-related problems per patient was 0.7 [95% CI 0.5-0.8] in phase 1 and 0.50 [95% CI 0.4-0.6] in phase 2. The difference in the prevalence of dosing inadequacy between the control and intervention group before the pharmacists' intervention was 0.73% [95% CI (-6.0) -7.5] and after the pharmacists' intervention it was 13.5% [95% CI 8.0 - 19.5] (p < 0.001) while the difference in the mean of drug-related problems per patient before the pharmacists' intervention was 0.05 [95% CI(-0.2) - 0.3] and following the intervention it was 0.5 [95% CI 0.3 - 0.7] (p < 0.001). Conclusion: A drug dosing adjustment service for elderly patients with renal impairment in community pharmacies can increase the proportion of adequate drug dosing, and improve the drug-related problems per patient. Collaborative practice with physicians can improve these results.
引用
收藏
页数:9
相关论文
共 29 条
[1]  
Abajo del Alamo C, 2009, REV ESP GERIATR GERO, V44, P266
[2]  
Alvarez Arroyo L, 2009, Farm Hosp, V33, P147
[3]  
[Anonymous], 2010, FIP STAT COLL PHARM
[4]   Cardiovascular disease and chronic renal failure or viceversa [J].
Bayes, Beatriz ;
Romero, Ramon .
MEDICINA CLINICA, 2008, 131 (02) :60-62
[5]   Improving Prescribing Safety in Patients with Renal Insufficiency in the Ambulatory Setting: The Drug Renal Alert Pharmacy (DRAP) Program [J].
Bhardwaja, Bharati ;
Carroll, Nikki M. ;
Raebel, Marsha A. ;
Chester, Elizabeth A. ;
Korner, Eli J. ;
Rocho, Bob E. ;
Brand, David W. ;
Magid, David J. .
PHARMACOTHERAPY, 2011, 31 (04) :346-356
[6]  
Bonal J, 2007, BIT, V19, P19
[7]   Prevalence of chronic kidney disease in the United States [J].
Coresh, Josef ;
Selvin, Elizabeth ;
Stevens, Lesley A. ;
Manzi, Jane ;
Kusek, John W. ;
Eggers, Paul ;
Van Lente, Frederick ;
Levey, Andrew S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17) :2038-2047
[8]   How to improve drug dosing for patients with renal impairment in primary care - a cluster-randomized controlled trial [J].
Erler, Antje ;
Beyer, Martin ;
Petersen, Juliana J. ;
Saal, Kristina ;
Rath, Thomas ;
Rochon, Justine ;
Haefeli, Walter E. ;
Gerlach, Ferdinand M. .
BMC FAMILY PRACTICE, 2012, 13
[9]   Comment: Use of Recalibrated Serum Creatinine Concentrations for Adjustment of Drug Dosages: Determination of Values Compatible with Conventional Dosing Recommendations [J].
Eugenia Palacio-Lacambra, M. ;
Jimenez-Lozano, Ines ;
Vidal-Otero, Jana ;
Bruno Montoro-Ronsano, Jose .
ANNALS OF PHARMACOTHERAPY, 2011, 45 (12) :1592-1593
[10]  
Fernandez-Vega F, 2009, HIPERTENSRIESGO VASC, V26, P2